MILTEX

This brand name is authorized in Lithuania, South Africa

Active ingredients

The drug MILTEX contains one active pharmaceutical ingredient (API):

1 Miltefosine
UNII 53EY29W7EC - MILTEFOSINE

Miltefosine has a marked direct antileishmanial activity in vitro and in animal models. Leishmania donovani was the most sensitive species in promastigote and amastigote test systems.

Read about Miltefosine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
P01CX04 Miltefosine P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01C Agents against leishmaniasis and trypanosomiasis → P01CX Other agents against leishmaniasis and trypanosomiasis
Discover more medicines within P01CX04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: LT Valstybinฤ— vaistลณ kontrolฤ—s tarnyba Identifier(s): 1003093
Country: ZA Health Products Regulatory Authority Identifier(s): 34/26/0001

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈